These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

478 related items for PubMed ID: 15466442

  • 1. Tedisamil attenuates foetal transformation of myosin in the hypertrophied rat myocardium.
    Turcani M, Thormaehlen D, Rupp H.
    Br J Pharmacol; 2004 Nov; 143(5):561-72. PubMed ID: 15466442
    [Abstract] [Full Text] [Related]

  • 2. Development of pressure overload induced cardiac hypertrophy is unaffected by long-term treatment with losartan.
    Turcani M, Rupp H.
    Mol Cell Biochem; 1998 Nov; 188(1-2):225-33. PubMed ID: 9823028
    [Abstract] [Full Text] [Related]

  • 3. Etomoxir improves left ventricular performance of pressure-overloaded rat heart.
    Turcani M, Rupp H.
    Circulation; 1997 Nov 18; 96(10):3681-6. PubMed ID: 9396471
    [Abstract] [Full Text] [Related]

  • 4. Effects of tedisamil on cardiovascular tissues isolated from normo- and hypertensive rats.
    Doggrell SA, Nand V.
    J Cardiovasc Pharmacol Ther; 2001 Jul 18; 6(3):261-72. PubMed ID: 11584333
    [Abstract] [Full Text] [Related]

  • 5. Modification of left ventricular hypertrophy by chronic etomixir treatment.
    Turcani M, Rupp H.
    Br J Pharmacol; 1999 Jan 18; 126(2):501-7. PubMed ID: 10077244
    [Abstract] [Full Text] [Related]

  • 6. Bradykinin (B2) independent effect of captopril on the development of pressure overload cardiac hypertrophy.
    Turcani M, Rupp H.
    Mol Cell Biochem; 2000 Sep 18; 212(1-2):219-25. PubMed ID: 11108154
    [Abstract] [Full Text] [Related]

  • 7. Myocardial contractility and ventricular myosin isoenzymes as influenced by cardiac hypertrophy and its regression.
    Tanamura A, Takeda N, Iwai T, Tuchiya M, Arino T, Nagano M.
    Basic Res Cardiol; 1993 Sep 18; 88(1):72-9. PubMed ID: 8471005
    [Abstract] [Full Text] [Related]

  • 8. In vivo profile of myocardial energy metabolism of pressure-overloaded rat.
    Takeo S, Tanonaka K, Aoki M, Nakai Y, Sanbe A, Shizume Y, Tanaka C, Miyake K, Hirai K, Ueda N.
    Jpn Heart J; 1993 May 18; 34(3):313-31. PubMed ID: 8411637
    [Abstract] [Full Text] [Related]

  • 9. Cardiac and hemodynamic effects of the sinus node inhibitor tedisamil dihydrochloride in patients with congestive heart failure due to dilated cardiomyopathy.
    Hermann HP, Ohler A, Just H, Hasenfuss G.
    J Cardiovasc Pharmacol; 1998 Dec 18; 32(6):969-74. PubMed ID: 9869503
    [Abstract] [Full Text] [Related]

  • 10. Altered myocardial contractility and energetics in hypertrophied myocardium.
    Takeda N, Nakamura I, Okubo T, Nagano M.
    Jpn Circ J; 1990 May 18; 54(5):540-6. PubMed ID: 2172580
    [Abstract] [Full Text] [Related]

  • 11. Cardiac contractile proteins in hypertrophied and failing guinea pig heart.
    Malhotra A, Siri FM, Aronson R.
    Cardiovasc Res; 1992 Feb 18; 26(2):153-61. PubMed ID: 1533346
    [Abstract] [Full Text] [Related]

  • 12. Antifibrillatory efficacy of long-term tedisamil administration in a postinfarcted canine model of ischemic ventricular fibrillation.
    Friedrichs GS, Abreu JN, Driscoll EM, Borlak J, Lucchesi BR.
    J Cardiovasc Pharmacol; 1998 Jan 18; 31(1):56-66. PubMed ID: 9456278
    [Abstract] [Full Text] [Related]

  • 13. Tedisamil blocks the transient and delayed rectifier K+ currents in mammalian cardiac and glial cells.
    Dukes ID, Cleemann L, Morad M.
    J Pharmacol Exp Ther; 1990 Aug 18; 254(2):560-9. PubMed ID: 2384886
    [Abstract] [Full Text] [Related]

  • 14. Myocardial changes during the progression of left ventricular pressure-overload by renal hypertension or aortic constriction: myosin, myosin ATPase and collagen.
    Kozlovskis PL, Fieber LA, Pruitt DK, Bailey BK, Smets MJ, Bassett AL, Kimura S, Myerburg RJ.
    J Mol Cell Cardiol; 1987 Jan 18; 19(1):105-14. PubMed ID: 2951526
    [Abstract] [Full Text] [Related]

  • 15. Different inhibition patterns of tedisamil for fast and slowly inactivating transient outward current in rat ventricular myocytes.
    Berger F, Borchard U, Hafner D, Weis TM.
    Naunyn Schmiedebergs Arch Pharmacol; 1998 Mar 18; 357(3):291-8. PubMed ID: 9550301
    [Abstract] [Full Text] [Related]

  • 16. Salutary effect of tedisamil on post-ischemic recovery rat heart: involvement of sarcolemmal (Na,K)-ATPase.
    Dzurba A, Ziegelhöffer A, Okruhlicová L, Vrbjar N, Styk J.
    Mol Cell Biochem; 2000 Dec 18; 215(1-2):129-33. PubMed ID: 11204448
    [Abstract] [Full Text] [Related]

  • 17. Tedisamil: master switch of nature?
    Doggrell SA.
    Expert Opin Investig Drugs; 2001 Jan 18; 10(1):129-38. PubMed ID: 11116286
    [Abstract] [Full Text] [Related]

  • 18. Contractile function, myosin ATPase activity and isozymes in the hypertrophied pig left ventricle after a chronic progressive pressure overload.
    Wisenbaugh T, Allen P, Cooper G, Holzgrefe H, Beller G, Carabello B.
    Circ Res; 1983 Sep 18; 53(3):332-41. PubMed ID: 6224606
    [Abstract] [Full Text] [Related]

  • 19. Na+/H+ exchange inhibition in hypertrophied myocardium subjected to cardioplegic arrest: an effective cardioprotective approach.
    Kevelaitis E, Qureshi AA, Mouas C, Marotte F, Kevelaitiene S, Avkiran M, Menasché P.
    Eur J Cardiothorac Surg; 2005 Jan 18; 27(1):111-6. PubMed ID: 15621481
    [Abstract] [Full Text] [Related]

  • 20. Tedisamil inactivates transient outward K+ current in rat ventricular myocytes.
    Dukes ID, Morad M.
    Am J Physiol; 1989 Nov 18; 257(5 Pt 2):H1746-9. PubMed ID: 2556052
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 24.